Rainsure Biological Closed on Tens of Millions of A Round Financing, Led By Bioventure

According to VCBeat, Suzhou Rainsure Biological Technology Co., LTD. (Rainsure Biological) announced that it had completed tens of millions of yuan A round of financing in Suzhou Industrial park, led by Bioventure, followed by old investors Future Capital and Volcanics Venture.

This round of financing will be used for the R&D of digital PCR system and supporting kit, and the expansion of the sales market. Before this financing, Rainsure Biological had got investment from Zhen Fund, Volcanics Venture and Future Capital.

Founded in October 2017, Rainsure Biological is committed to promoting the application and innovation of technologies including digital PCR in medical health, food safety, inspection and quarantine and other big health fields through innovation, intelligent manufacturing, and health service.

Rainsure Biological has completed the commercialization of digital PCR products and launched two generations of digital PCR system including Dropx-1000, Dropx-2000. Totally, Rainsure Biological has launched more than 50 kinds of digital PCR kits in China, for the detection of tumor point mutations (including non-small cell lung cancer, colorectal cancer, melanoma, breast cancer, gastric cancer, and other cancers), gene fusion detection and copy number variation.

Founded in September 2013, Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) manages the new bio-industry funds of 540 million yuan. Bioventure invests in life sciences companies such as biotechnology, drug discovery, medical devices and healthcare services companies in the early stages. It provides capital, management, operation and other post-investment support and services.

Founded in 2014, Future Capital is one of the venture capital firms focused on China's technology companies in the early stage. It manages funds of 2.5 billion yuan. Future Capital pays attention to the fields of artificial intelligence and big data, enterprise services, intelligent travel, intelligent logistics, medical informatization and smart home.